BIVACQUA, Roberta
BIVACQUA, Roberta
Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis
2024-08-28 Scalia F.; Culletta G.; Barreca M.; Caruso Bavisotto C.; Bivacqua R.; D'Amico G.; Alberti G.; Spano' V.; Tutone M.; Almerico A.M.; Cappello F.; Montalbano A.; Barraja P.
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines
2024-10-04 Maria Valeria Raimondi; Salvatrice Rigogliuso; Filippo Saiano; Paola Poma; Manuela Labbozzetta; Marilia Barreca; Marcella Barbera; Roberta Bivacqua; Giovanna Li Petri; Silvestre Buscemi; Ignazio Sardo; Virginia Spano; Antonio Palumbo Piccionello; Alessandra Montalbano; Paola Barraja; Monica Notarbartolo
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas
2022-12-05 Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Abel A.-C.; Maruca A.; Montalbano A.; Raimondi M.V.; Tarantelli C.; Gaudio E.; Cascione L.; Rinaldi A.; Bai R.; Steinmetz M.O.; Prota A.E.; Alcaro S.; Hamel E.; Bertoni F.; Barraja P.
EXPLORING TRIAZOLE AND THIAZOLE SYSTEMS FOR ANTIVIRAL APPLICATIONS: SYNTHESIS AND BIOLOGICAL EVALUATION
2024-06-27
GPCR Inhibition in Treating Lymphoma
2022-02-15 Barreca M.; Spano' V.; Raimondi M.V.; Bivacqua R.; Giuffrida S.; Montalbano A.; Cavalli A.; Bertoni F.; Barraja P.
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches
2023-04-11 Bivacqua R.; Romeo I.; Barreca M.; Barraja P.; Alcaro S.; Montalbano A.
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis
2024-01-01 Barreca M.; Renda M.; Spano' V.; Montalbano A.; Raimondi M.V.; Giuffrida S.; Bivacqua R.; Bandiera T.; Galietta L.J.V.; Barraja P.
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas
2023-06-05 Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Gualtieri G.; Raimondi M.V.; Gaudio E.; Bortolozzi R.; Manfreda L.; Bai R.; Montalbano A.; Alcaro S.; Hamel E.; Bertoni F.; Viola G.; Barraja P.
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors
2023-03-05 Bivacqua R.; Barreca M.; Spano' V.; Raimondi M.V.; Romeo I.; Alcaro S.; Andrei G.; Barraja P.; Montalbano A.
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel
2023-05-10 Renda M.; Barreca M.; Borrelli A.; Spano' V.; Montalbano A.; Raimondi M.V.; Bivacqua R.; Musante I.; Scudieri P.; Guidone D.; Buccirossi M.; Genovese M.; Venturini A.; Bandiera T.; Barraja P.; Galietta L.J.V.
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma
2022-01-01 Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Maruca A.; Montalbano A.; Raimondi M.V.; Tarantelli C.; Gaudio E.; Cascione L.; Rinaldi A.; Bai R.; Prota A.; Abel A.C.; Steinmetz M.; Alcaro S.; Hamel E.; Bertoni F.; Barraja P.
| Data di pubblicazione | Titolo | Autori | Tipologia | Autore(i) | File |
|---|---|---|---|---|---|
| 28-ago-2024 | Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis | Scalia F.Culletta G.Barreca M.Caruso Bavisotto C.Bivacqua R.D'Amico G.Alberti G.Spano' V.Tutone M.Almerico A. M.Cappello F.Montalbano A.Barraja P. | 01 - Contributo in rivista::1.01 Articolo in rivista | Scalia F.; Culletta G.; Barreca M.; Caruso Bavisotto C.; Bivacqua R.; D'Amico G.; Alberti G.; Spano' V.; Tutone M.; Almerico A.M.; Cappello F.; Montalbano A.; Barraja P. | |
| 4-ott-2024 | Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines | Maria Valeria RaimondiSalvatrice RigogliusoFilippo SaianoPaola PomaManuela LabbozzettaMarilia BarrecaMarcella BarberaRoberta BivacquaGiovanna Li PetriSilvestre BuscemiIgnazio SardoVirginia SpanoAntonio Palumbo PiccionelloAlessandra MontalbanoPaola BarrajaMonica Notarbartolo | 01 - Contributo in rivista::1.01 Articolo in rivista | Maria Valeria Raimondi; Salvatrice Rigogliuso; Filippo Saiano; Paola Poma; Manuela Labbozzetta; Marilia Barreca; Marcella Barbera; Roberta Bivacqua; Giovanna Li Petri; Silvestre Buscemi; Ignazio Sardo; Virginia Spano; Antonio Palumbo Piccionello; Alessandra Montalbano; Paola Barraja; Monica Notarbartolo | |
| 5-dic-2022 | Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas | Barreca M.Spano' V.Bivacqua R.Montalbano A.Raimondi M. V.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Abel A.-C.; Maruca A.; Montalbano A.; Raimondi M.V.; Tarantelli C.; Gaudio E.; Cascione L.; Rinaldi A.; Bai R.; Steinmetz M.O.; Prota A.E.; Alcaro S.; Hamel E.; Bertoni F.; Barraja P. | |
| 27-giu-2024 | EXPLORING TRIAZOLE AND THIAZOLE SYSTEMS FOR ANTIVIRAL APPLICATIONS: SYNTHESIS AND BIOLOGICAL EVALUATION | BIVACQUA, Roberta | 04 - Tesi di dottorato::4.2 Tesi di dottorato | - | |
| 15-feb-2022 | GPCR Inhibition in Treating Lymphoma | Barreca M.Spano' V.Raimondi M. V.Bivacqua R.Giuffrida S.Montalbano A.Barraja P. + | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Barreca M.; Spano' V.; Raimondi M.V.; Bivacqua R.; Giuffrida S.; Montalbano A.; Cavalli A.; Bertoni F.; Barraja P. | |
| 11-apr-2023 | HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches | Bivacqua R.Barreca M.Barraja P.Montalbano A. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Bivacqua R.; Romeo I.; Barreca M.; Barraja P.; Alcaro S.; Montalbano A. | |
| 1-gen-2024 | Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis | Barreca M.Spano' V.Montalbano A.Raimondi M. V.Giuffrida S.Bivacqua R.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca M.; Renda M.; Spano' V.; Montalbano A.; Raimondi M.V.; Giuffrida S.; Bivacqua R.; Bandiera T.; Galietta L.J.V.; Barraja P. | |
| 5-giu-2023 | Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas | Barreca M.Spano' V.Bivacqua R.Raimondi M. V.Montalbano A.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Gualtieri G.; Raimondi M.V.; Gaudio E.; Bortolozzi R.; Manfreda L.; Bai R.; Montalbano A.; Alcaro S.; Hamel E.; Bertoni F.; Viola G.; Barraja P. | |
| 5-mar-2023 | Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors | Bivacqua R.Barreca M.Spano' V.Raimondi M. V.Barraja P.Montalbano A. + | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Bivacqua R.; Barreca M.; Spano' V.; Raimondi M.V.; Romeo I.; Alcaro S.; Andrei G.; Barraja P.; Montalbano A. | |
| 10-mag-2023 | Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel | Barreca M.Borrelli A.Spano' V.Montalbano A.Raimondi M. V.Bivacqua R.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Renda M.; Barreca M.; Borrelli A.; Spano' V.; Montalbano A.; Raimondi M.V.; Bivacqua R.; Musante I.; Scudieri P.; Guidone D.; Buccirossi M.; Genovese M.; Venturini A.; Bandiera T.; Barraja P.; Galietta L.J.V. | |
| 1-gen-2022 | Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma | Barreca M.Spano' V.Bivacqua R.Montalbano A.Raimondi M. V.Barraja P. + | 01 - Contributo in rivista::1.05 Abstract in atti di convegno pubblicato in rivista | Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Maruca A.; Montalbano A.; Raimondi M.V.; Tarantelli C.; Gaudio E.; Cascione L.; Rinaldi A.; Bai R.; Prota A.; Abel A.C.; Steinmetz M.; Alcaro S.; Hamel E.; Bertoni F.; Barraja P. |